Cerebri: A Web-App to Reduce Door-to-Treatment Decision Time and Improve Guideline Adherence in Acute Ischemic Stroke
Cerebri: Eine Web-App zur Verkürzung der Door-to-Treatment-Entscheidungszeit und Verbesserung der Leitlinienadhärenz bei akutem ischämischem Schlaganfall
Stroke · 2026-02 · 57 (2) · 371-380
DOI: 10.1161/strokeaha.125.052997 ↗Auf einen Blick
In einer Pilotstudie verkürzte die App cerebri die Imaging-to-Decision-Zeit und erhöhte die Leitlinienadhärenz bei akutem ischämischem Schlaganfall.
Fragestellung
Verbessert die stroke-spezifische klinische Entscheidungsunterstützung per Smartphone-App die Entscheidungszeit und Leitlinienadhärenz bei akutem ischämischem Schlaganfall?
Methode
Prospektive, monozentrische, kalender-tage-randomisierte Pilotstudie in der Notaufnahme eines Universitätskrankenhauses in Rom vom 1. Dezember 2024 bis 30. März 2025.
Ergebnisse
50 Patient:innen wurden eingeschlossen (25 cerebri, 25 Kontrolle). Median Imaging-to-Decision-Zeit: 6 vs. 22 Minuten; adjustierte Differenz −18,8 Minuten (95 %-KI −37,4 bis −3,5). Gesamtadhärenz: 96 % vs. 73,9 %; adjustierte OR 11,6 (95 %-KI 1,12–121,16).
Schlussfolgerung der Autor:innen
Cerebri verbesserte die Entscheidungsgeschwindigkeit und die Leitlinienadhärenz in der hyperakuten Versorgung des ischämischen Schlaganfalls.
Kernaussagen
- Median 6 vs. 22 Minuten Imaging-to-Decision-Zeit
- Gesamtadhärenz 96 % vs. 73,9 %
- Feasibility und Effektivität auch in nicht tertiären Schlaganfallzentren
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2026-02. Verfasst von Adriano Bonura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain (A.B.). Hauptthemen laut MEDLINE: Guideline Adherence, Ischemic Stroke, Time-to-Treatment, Decision Support Systems, Clinical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Clinical decision support systems hold promise for improving adherence to guidelines and reducing decision-making time in acute ischemic stroke management. We developed a stroke-specific clinical decision support system smartphone app termed cerebri and assessed its efficacy in reducing imaging-to-decision time and enhancing guideline adherence in a real-world clinical setting. METHODS: We conducted a prospective, single-center, calendar-day-randomized pilot study at the Emergency Department of Campus Bio-Medico University Hospital in Rome, Italy, from December 1, 2024, to March 30, 2025 (80 effective study days). Eligible participants were adult patients (≥18 years) with suspected ischemic stroke presenting within 24 hours of symptom onset. Randomization occurred by day, assigning patients to either the cerebri group (app providing clinical decision support plus a timer function) or the control group (timer function only, without decision support). The app was used by the neurologist on-call that workday. Primary outcomes were imaging-to-decision time (imaging to decision time: the time from imaging completion to therapeutic decision, in minutes) and adherence to European Stroke Organization guidelines. Guideline adherence was expressed as the percentage of cases compliant, and assessed separately for diagnostic decisions (appropriate imaging modality), therapeutic decisions (appropriate treatment choice), and overall adherence (compliance with both diagnostic and therapeutic domains). Multivariable linear and logistic regression analyses adjusted for age, National Institutes of Health Stroke Scale, and revascularization therapies were performed. RESULTS: Fifty patients (mean age, 73.1±13.3 years; 64% female) were enrolled (25 cerebri, 25 control). Patients in the cerebri group had significantly reduced median imaging to decision time (6 versus 22 minutes; adjusted difference: −18.8 minutes [95% CI, −37.4 to −3.5]; P=0.009). Overall guideline adherence was significantly higher in the cerebri group (96% versus 73.9%; adjusted odds ratio, 11.6 [95% CI, 1.12–121.16]; P =0.040). Therapeutic guideline adherence was 100% in the cerebri group versus 86.9% in the control ( P =0.062). CONCLUSIONS: Cerebri significantly improved decision-making speed and adherence to stroke guidelines in the hyperacute management of ischemic stroke. The app demonstrated feasibility and efficacy even in nontertiary stroke centers, suggesting its potential for broader implementation to enhance stroke care quality and equity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stroke Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain (A.B.).
- Bioengineering Unit, Ri.MED Foundation, Palermo, Italy (G.M.).
- Neurology Department, I.R.C.C.S. Policlinico San Donato, Milan, Italy (S.S.R.).
- Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, Campus Bio-Medico University, Rome, Italy (F.S., M.S., V.D.L., F.P.).
- IFFALSE SRLS, Palermo, Italy (P.P.).
- Neurology Department, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy (V.D.L., F.P.).
ORCID-Profile: Adriano Bonura, Giulio Musotto, Francesca Santoro, Marco Sferruzzi, Vincenzo Di Lazzaro, Fabio Pilato
Zitieren
APA
Bonura, A., Musotto, G., Rossi, S. S., Santoro, F., Pillitteri, P., Sferruzzi, M., Di Lazzaro, V., Pilato, F., & Cerebri Study Group Collaborators (2026). Cerebri: A Web-App to Reduce Door-to-Treatment Decision Time and Improve Guideline Adherence in Acute Ischemic Stroke. Stroke, 57(2), 371-380. https://doi.org/10.1161/strokeaha.125.052997
Vancouver
Bonura A, Musotto G, Rossi SS, Santoro F, Pillitteri P, Sferruzzi M, et al. Cerebri: A Web-App to Reduce Door-to-Treatment Decision Time and Improve Guideline Adherence in Acute Ischemic Stroke. Stroke. 2026;57(2):371-380. doi:10.1161/strokeaha.125.052997
BibTeX
@article{Bonura2026,
author = {Bonura, Adriano and Musotto, Giulio and Rossi, Sergio Soeren and Santoro, Francesca and Pillitteri, Pasquale and Sferruzzi, Marco and Di Lazzaro, Vincenzo and Pilato, Fabio and Cerebri Study Group Collaborators, Cerebri Study Group Collaborators},
title = {Cerebri: A Web-App to Reduce Door-to-Treatment Decision Time and Improve Guideline Adherence in Acute Ischemic Stroke},
journal = {Stroke},
year = {2026},
volume = {57},
number = {2},
pages = {371--380},
doi = {10.1161/strokeaha.125.052997}
}
EUVIMED